Enhanced co-stimulatory ability of synovial fluid accessory cells in rheumatoid arthritis.

We have established in vitro assays that allow the examination of co-stimulatory function of rheumatoid arthritis (RA) antigen-presenting cells (APC). Synovial fluid (SF) and peripheral blood (PB) APC co-stimulatory ability was compared in the activation of peptide-specific human T-cell clones. T-cell receptor (TCR) stimulation by peptide or anti-CD3 antibody allowed the direct comparison of SF and PB APC co-stimulatory activity, separately from their ability to process antigen. SF APC from 15 RA patients consistently enhanced T-cell proliferation when compared to their PB counterparts. Moreover, increasing the numbers of PB APC present resulted in only a minor increase in T-cell proliferation, failing to achieve levels stimulated by SF APC. We propose that the enhanced co-stimulatory function of synovial APC may be a significant factor in the persistence of local immune responses in RA.

[1]  M. Hooper,et al.  Costimulatory activity of human synovial fibroblasts. , 1995, The Journal of rheumatology.

[2]  J. Bluestone New perspectives of C1328-137-mediated T cell costimulation , 1995 .

[3]  D. Eckels,et al.  Differential activation through the TCR-CD3 complex affects the requirement for costimulation of human T cells. , 1995, Human immunology.

[4]  N. Viner Role of antigen presenting cells in rheumatoid arthritis. , 1995, British medical bulletin.

[5]  J. Bluestone New perspectives of CD28-B7-mediated T cell costimulation. , 1995, Immunity.

[6]  E. Gelfand,et al.  Human CD45RA+ and CD45R0+ T cells exhibit similar CD3/T cell receptor‐mediated transmembrane signaling capacities but differ in response to co‐stimulatory signals , 1994, European journal of immunology.

[7]  P. Linsley,et al.  Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor alpha leads to autoimmunity in transgenic mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[8]  E. Shevach,et al.  Activation of CD4+ T cells by delivery of the B7 costimulatory signal on bystander antigen‐presenting cells (trans‐costimulation) , 1994, European journal of immunology.

[9]  N. Viner,et al.  A longitudinal study of peripheral blood mononuclear cell proliferative responses to bacterial antigens in reactive arthritis. , 1994, British journal of rheumatology.

[10]  J. Bluestone,et al.  Expression and functional significance of an additional ligand for CTLA-4. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[11]  L. Lanier,et al.  B70 antigen is a second ligand for CTLA-4 and CD28 , 1993, Nature.

[12]  N. Viner,et al.  Synovial fluid antigen‐presenting cell function in rheumatoid arthritis , 1993, Clinical and experimental immunology.

[13]  P. Linsley,et al.  The role of the CD28 receptor during T cell responses to antigen. , 1993, Annual review of immunology.

[14]  E. Celis,et al.  Peptide-induced proliferation and lymphokine production in human T cells in the absence of antigen-presenting cells: role of T-cell activation state and costimulatory signals. , 1992, Human immunology.

[15]  C. Janeway,et al.  Cells that present both specific ligand and costimulatory activity are the most efficient inducers of clonal expansion of normal CD4 T cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Allison,et al.  CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones , 1992, Nature.

[17]  M. Jenkins,et al.  CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. , 1991, Journal of immunology.

[18]  G. Freeman,et al.  Selective induction of B7/BB-1 on interferon-gamma stimulated monocytes: a potential mechanism for amplification of T cell activation through the CD28 pathway. , 1991, Cellular immunology.

[19]  G. Firestein The immunopathogenesis of rheumatoid arthritis , 1991, Current opinion in rheumatology.

[20]  E. Unanue,et al.  The costimulatory function of antigen-presenting cells. , 1990, Immunology today.

[21]  R. Schwartz,et al.  Allogeneic non-T spleen cells restore the responsiveness of normal T cell clones stimulated with antigen and chemically modified antigen-presenting cells. , 1988, Journal of immunology.

[22]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[23]  R. Steinman,et al.  Identification of immunostimulatory dendritic cells in the synovial effusions of patients with rheumatoid arthritis. , 1985, The Journal of clinical investigation.

[24]  M. E. Kaplan,et al.  An improved rosetting assay for detection of human T lymphocytes. , 1974, Journal of immunological methods.